Today, Sun Pharmaceutical Industries has reported a two fold jump in consolidated net profit. It stands now at Rs 1852.48 crore for the December quarter whereas earlier in the same quarter last year it was at Rs 913.52 crore. The numbers were aided by other income.
As reported by Economic Times, their analysts have reported profit figure at Rs 1260 crore.
Other income for the quarter is at Rs 314.95 crore compared to Rs 119.88 crore in the year ago period. Revenue for the third quarter surged by 9.2% year-on-year to achieve Rs 8781.84 crore compared to Rs 8038.65 crore in the same quarter period last year.
The company board declared an interim dividend of Rs 5.50 per share. The record date fixed for the purpose of ascertaining the entitlement is February 10.
Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra it manufactures and sells primarily in India and the US.
The Indian pharmaceutical industry has become the third largest producer in the world in terms of volumes. In terms of value India still stands at number 14 in the world.
